AC Immune (ACIU) Operating Income (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.86% |
| Dec 31, 2025 | 10.89% |
| Sep 30, 2025 | 13.70% |
| Jun 30, 2025 | -8.70% |
| Mar 31, 2025 | -1.37% |
| Dec 31, 2024 | -353.31% |
| Sep 30, 2024 | 136.20% |
| Jun 30, 2024 | -0.81% |
| Mar 31, 2024 | -475.95% |
| Dec 31, 2023 | 77.20% |
| Sep 30, 2023 | 7.64% |
| Jun 30, 2023 | 0.21% |
| Mar 31, 2023 | 2.12% |
| Dec 31, 2022 | -39.22% |
| Sep 30, 2022 | 32.39% |
| Jun 30, 2022 | -1.13% |
| Mar 31, 2022 | 17.49% |
| Dec 31, 2021 | -11.87% |
| Sep 30, 2021 | -7.79% |
| Jun 30, 2021 | -7.41% |
| Mar 31, 2021 | 11.38% |
| Dec 31, 2020 | -5.40% |
| Sep 30, 2020 | -25.48% |
| Jun 30, 2020 | -115.66% |
| Mar 31, 2020 | 60.31% |
| Dec 31, 2019 | -204.23% |
| Sep 30, 2019 | 223.83% |
| Jun 30, 2019 | -124.39% |
| Mar 31, 2019 | 514.89% |
| Dec 31, 2018 | -17.68% |
| Sep 30, 2018 | -5.24% |
| Jun 30, 2018 | 1.54% |
| Mar 31, 2017 | -156.29% |
| Dec 31, 2016 | 267.42% |
| Mar 31, 2016 | 8.61% |
| Dec 31, 2015 | -131.77% |